Cargando…
Aspartate-β-hydroxylase (ASPH): A potential therapeutic target in human malignant gliomas
BACKGROUND: Despite therapeutic advances, survival with glioblastoma multiforme (GBM) remains below 15 months from diagnosis due to GBM’s highly infiltrative nature which precludes complete surgical resection. Patient outcomes could potentially be improved by targeting genes and pathways that drive...
Autores principales: | Sturla, Lisa-Marie, Tong, Ming, Hebda, Nick, Gao, Jinsong, Thomas, John-Michael, Olsen, Mark, de la Monte, Suzanne M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5144823/ https://www.ncbi.nlm.nih.gov/pubmed/27981247 http://dx.doi.org/10.1016/j.heliyon.2016.e00203 |
Ejemplares similares
-
Aspartate β-Hydroxylase (ASPH) Expression in Acute Myeloid Leukemia: A Potential Novel Therapeutic Target
por: Holtzman, Noa G., et al.
Publicado: (2021) -
Ethanol-Induced White Matter Atrophy Is Associated with Impaired Expression of Aspartyl-Asparaginyl-β-Hydroxylase (ASPH) and Notch Signaling in an Experimental Rat Model
por: Tong, Ming, et al.
Publicado: (2017) -
Aspartate β-hydroxylase expression promotes a malignant pancreatic cellular phenotype
por: Dong, Xiaoqun, et al.
Publicado: (2014) -
Hydroxylase Activity of ASPH Promotes Hepatocellular Carcinoma Metastasis Through Epithelial-to-Mesenchymal Transition Pathway
por: Zou, Qifei, et al.
Publicado: (2018) -
Aspartate β-hydroxylase as a target for cancer therapy
por: Kanwal, Madiha, et al.
Publicado: (2020)